**Title: Hospira Recalls Sodium Chloride Injection Due to Brass Particulates**
**Overview**
Hospira, Inc. has issued a voluntary recall of one lot of 0.9% Sodium Chloride Injection, USP, 1000 mL, Flexible Container. This is a nationwide user-level recall affecting healthcare facilities, including hospitals and pharmacies. The recall was initiated after detecting brass particulates in the solution, posing potential health risks to patients.
**Details of the Recall**
– **Product Details:** 0.9% Sodium Chloride Injection, USP, 1000 mL, Flexible Container
– **NDC Number:** 0409-7983-09
– **Reason for Recall:** Presence of brass particulates in the product
– **Recall Level:** User level (hospitals and pharmacies nationwide)
**Potential Risks**
The presence of brass particulates can lead to serious health consequences if the solution is administered to patients. Particulates can cause blockages of blood vessels, which could lead to tissue damage and organ dysfunction. Additionally, such foreign particles can result in immune reactions and systemic infections.
**Actions for Risk Managers and Pharmacists**
– Immediately review your inventory for the affected lot and quarantine it.
– Cease the distribution and use of any product from the recalled lot.
– Report any adverse events related to this product to the FDA MedWatch program.
**Next Steps**
Hospira is taking necessary measures to recover the affected product from the market.